Hudson Bay Capital Management
IMUX icon

Hudson Bay Capital Management’s Immunic IMUX Stock Holding History

Hudson Bay Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Buy
+21,302
New +$191K ﹤0.01% 1076
2025
Q2 		– Sell
-1,457
Closed -$15.9K – 1509
2025
Q1 		$15.9K Buy
+1,457
New +$15.7K ﹤0.01% 1236
2020
Q3 		– Sell
-12,305
Closed -$1.49M – 595
2020
Q2 		$1.49M Buy
+12,305
New +$1.25M 0.03% 341

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Hudson Bay Capital Management's IMUX Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Immunic (IMUX) in Q1 2026: 21,302 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #1076 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in IMUX as recently as Q1 2025.

Hudson Bay Capital Management first reported a position in IMUX in Q2 2020 and has held it in 3 quarters since. The position peaked at $1.49M in Q2 2020. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Hudson Bay Capital Management held 21,302 shares of Immunic worth $236K as of Q1 2026.
  • Immunic was a new Hudson Bay Capital Management position in Q1 2026.
  • Immunic made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1076 holding.
  • Hudson Bay Capital Management first reported a position in Immunic in Q2 2020 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Immunic position peaked at $1.49M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.